Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Gene test for KarXT: healthy volunteers needed to unlock drug metabolism secrets

NCT ID NCT07204418

First seen Oct 31, 2025 · Last updated May 21, 2026 · Updated 27 times

Summary

This study looks at how a person's genes (specifically CYP2D6) affect the way their body processes the drug KarXT. It involves 56 healthy adults who are grouped by their gene type. The goal is to understand drug levels and safety, not to treat any disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

Locations

  • Anaheim Clinical Trials

    RECRUITING

    Anaheim, California, 92801, United States

    Contact Phone: •••-•••-••••

  • ICON - Lenexa

    RECRUITING

    Lenexa, Kansas, 66219-9746, United States

    Contact Phone: •••-•••-••••

  • ICON Development Solutions

    RECRUITING

    San Antonio, Texas, 78209, United States

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.